A study to assess the safety and tolerability of single and multiple doses of AZD4831 in healthy male subjects

Trial Identifier: D6580C00001
Sponsor: AstraZeneca
NCTID:: NCT02712372
Start Date: June 2016
Primary Completion Date: October 2016
Condition: Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English translation
German translation

Trial Locations

Country Location
Germany Berlin, Germany, 14050